Search all trials

Find therapies in clinical trials near you – page 8

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Schizophrenia

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo

Poland

Participants:18–64 years
Substances:Iclepertin

Contact Research Centre

Breast cancer

Not recruiting

Registered drug

Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

InvestigationalNo placebo

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride

Contact Research Centre

Choroidal neovascularisation

Not recruiting

Registered drugNo placebo

Faricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Faricimab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

A study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Acute myocardial infarction

Not recruiting

Investigational

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ziltivekimab

Contact Research Centre

Myasthenia gravis+1

Not recruiting

Investigational

Study of Descartes-08 compared to placebo in adults with generalized myasthenia gravis

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Adenocarcinoma gastric+3

Not recruiting

Registered drug

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Acromegaly

Not recruiting

Registered drug

Study of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:ALXN2420

Contact Research Centre

Glioblastoma

Not recruiting

Registered drug

Study on the Effectiveness of Optune with Temozolomide and Pembrolizumab in Patients with Newly Diagnosed Glioblastoma

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drug

Study of INBRX-106 and Pembrolizumab for First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Find therapies in clinical trials near you – page 8

163 trials match your criteria

Schizophrenia

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

Breast cancer

Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

Acute myeloid leukaemia+1

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Choroidal neovascularisation

Faricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia

Squamous cell carcinoma of head and neck

Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Squamous cell carcinoma of head and neck

A study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery

Acute myocardial infarction

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Myasthenia gravis+1

Study of Descartes-08 compared to placebo in adults with generalized myasthenia gravis

Adenocarcinoma gastric+3

Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

Acromegaly

Study of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels

Glioblastoma

Study on the Effectiveness of Optune with Temozolomide and Pembrolizumab in Patients with Newly Diagnosed Glioblastoma

Squamous cell carcinoma of head and neck

Study of INBRX-106 and Pembrolizumab for First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.